SENEFOL

This brand name is authorized in Lithuania, Poland.

Active ingredients

The drug SENEFOL contains one active pharmaceutical ingredient (API):

`1`	Sennosides UNII `3FYP5M0IJX` - SENNOSIDES
	The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses.
	Read more about Sennosides

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AB06	Senna glycosides	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1021290, 1021291, 1021292, 1021293, 1021294, 1021295, 1021300, 1021301
PL	Rejestru Produktów Leczniczych	100242042

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.